Secondary Stock Offerings
By The Online Investor Staff, updated Fri., Mar. 29, 8:39 AM
Slide #12. Stevanato Group S.p.A. — Secondary Offering
Company: |
Stevanato Group S.p.A. (NYSE:STVN) |
Date announced: |
3/20/2024 |
Shares Offered: |
12,700,000 |
Date of Pricing: |
3/21/2024 |
Price Per Share: |
$26.00 |
Secondary Offering Details: |
Stevanato Group S.p.A. (NYSE:STVN) ("Stevanato Group," or the "Company"), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares. -updated 3/21- Stevanato Group S.p.A. (NYSE:STVN) ("Stevanato Group," or the "Company"), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share. Stevanato Group is offering 6,350,000 ordinary shares (the "Company Offering"), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the "Selling Shareholder"), which currently holds approximately 78% of Stevanato Group's outstanding ordinary shares, is offering 6,350,000 ordinary shares (the "Selling Shareholder Offering" and, together with the Company Offering, the "Offering"). Stevanato Group and the Selling Shareholder have granted the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase up to 1,905,000 additional ordinary shares on the same terms and conditions. |
Stevanato Group is engaged in the design, production and distribution of products and processes to provide integrated solutions for pharma and healthcare, leveraging on constant investment and the acquisition of skills of new technologies that has brought to become a global player in the pharma industry. Principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, glass forming machines. Co. operates its business in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering.
Open the STVN Page at The Online Investor »
Company Name: |
Stevanato Group SpA |
Website: |
www.stevanatogroup.com |
Sector: |
Shipping |
Number of ETFs Holding STVN: |
2 |
Total Market Value Held by ETFs: |
$1.09M |
|
Open the STVN Page at The Online Investor (in a new window) »
|
March 29, 2024 8:39 AM Eastern
Buy (3.33 out of 4)
46th percentile
|
|